January 12, 2023
CLEVELAND, Ohio USA – The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted an ADDF-Harrington Scholar Award to Christiane Wrann, PhD, DVM, Associate Professor in Medicine at the Cardiovascular Research Center and the McCance Center for...
Continue Reading
June 01, 2022
Focus on epigenetics, neurovascular health, and other novel approaches Continue Reading
April 28, 2022
More than 150 drug discovery projects now supported by Harrington Discovery Institute Continue Reading
April 25, 2022
Novel CryptigenTM technology unlocks full potential of Tumour Specific Antigens Continue Reading
April 12, 2022
Potential clinical trial to investigate use in COVID-19 Continue Reading
March 24, 2022
2022 Harrington Prize for Innovation in Medicine Recognizes Breakthrough Innovations in the Use of Human Antibodies to Treat COVID-19March 24, 2022, Cleveland, Ohio – The ninth annual Harrington Prize for Innovation in Medicine has been jointly awarded to James E. Crowe, Jr., MD, Director, Vanderbilt Vaccine Center and... Continue Reading
February 23, 2022
February 23, 2022, CLEVELAND, Ohio USA - Harrington Discovery Institute at University Hospitals is now accepting the Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical... Continue Reading
February 05, 2022
Chiesi Acquires Pioneering Therapeutic Monoclonal Antibodies Portfolio Against EMAP II as Potential Treatment for PAH Continue Reading
January 24, 2022
Linda and Les Vinney committed $1.25 million to establish the Linda and Les Vinney Scholar Program at Harrington Discovery Institute's Center for Brain Health Medicine, which will support new treatments for patients living with Alzheimer's disease. The gift also creates the Linda and Les Vinney Acceleration Awards, which will... Continue Reading
January 18, 2022
Four Medicines in Clinical Trials and More in the Pipeline Continue Reading
December 09, 2021
New Orleans, LA – LSU Health New Orleans entered into an exclusive option and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) granting Takeda the exclusive right to develop further a technology invented at LSU Health New Orleans with the aim to discover potential therapeutics to treat rare... Continue Reading